Mineralys Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $34 |
Gross Profit | -15 | -16 | -15 | 17 |
EBITDA | -36,917 | -46,730 | -44,432 | -51,752 |
EBIT | -36,932 | -46,746 | -44,447 | -51,767 |
Net Income | -36,932 | -43,274 | -42,211 | -48,946 |
Net Change In Cash | 0 | 0 | 0 | 34 |
Free Cash Flow | -28,872 | -30,169 | -45,487 | -66,843 |
Cash | 217,597 | 101,788 | 165,007 | 114,091 |
Basic Shares | 70,594 | 65,451 | 53,163 | 49,957 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -43 | |||
EBITDA | -192,360 | -84,657 | -31,479 | -19,381 |
EBIT | -192,403 | -84,824 | -31,479 | -37,449 |
Net Income | -177,810 | -71,898 | -29,799 | -19,408 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -166,410 | -81,173 | -29,221 | -14,559 |
Cash | 114,091 | 49,304 | 87,701 | 10,612 |
Basic Shares | 48,539 | 36,188 | 5,167 | 4,984 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.52 |
2025-06-30 | -$0.66 |
2025-03-31 | -$0.79 |
2024-12-31 | -$0.98 |
